Transactions
Aug. 21, 2001
Wilson Sonsini: CIPHERGEN PLANS PURCHASE OF INVITROGEN SUBSIDIARY
Ciphergen Biosystems Inc. will buy BioSepra S.A., a wholly owned subsidiary of Invitrogen Corp., for $12 million in cash. Ciphergen and Invitrogen have agreed to collaborate on integrating the technologies and products of both companies.




Ciphergen and Invitrogen have agreed to collaborate on integrating the technologies and products of both companies.
Located in Fremont, Ciphergen does proteomics, protein-based research. It develops, m...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In